An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming

被引:15
作者
Bishop, KI
Curran, HV
机构
[1] Novartis Pharma AG, Clin Res, CH-4002 Basel, Switzerland
[2] UCL, London WC1E 6BT, England
关键词
benzodiazepines; flumazenil; scopolamine; implicit memory; explicit memory; conceptual priming;
D O I
10.1007/s002130050775
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Scopolamine and lorazepam both produce anterograde impairments of explicit memory but only lorazepam impairs implicit memory as assessed by perceptual priming tasks. The main aim of the two experiments reported in this article was to determine the effects of these drugs on conceptual priming. Experiment 1 compared the effects of lorazepam (1,2 mg PO) with scopolamine (0.3, 0.6 mg SC) and placebo in a study with 60 healthy volunteers. Experiment 2 compared the separate and combined effects of lorazepam (2 mg PO) and flumazenil (2 mg IV) with placebo in a study with 48 healthy volunteers. We found that conceptual priming in category generation tasks was intact following lorazepam in both studies. This preservation of conceptual priming contrasted with lorazepam-induced impairments on explicit memory tasks. In conjunction with previous findings, these results are interpreted as providing further support for the notion that conceptual and perceptual priming are subserved by distinct memory systems, one based on the operations of semantic memory, the other possibly based on a perceptual representation system. That lorazepam impairs perceptual but not conceptual priming suggests that the neurochemical substrates of the two kinds of priming are distinct.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 40 条
[1]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[2]   CATEGORY NORMS FOR VERBAL ITEMS IN 56 CATEGORIES - A REPLICATION AND EXTENSION OF CONNECTICUT CATEGORY NORMS [J].
BATTIG, WF ;
MONTAGUE, WE .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY, 1969, 80 (3P2) :1-&
[3]   PSYCHOPHARMACOLOGICAL ANALYSIS OF IMPLICIT AND EXPLICIT MEMORY - A STUDY WITH LORAZEPAM AND THE BENZODIAZEPINE ANTAGONIST FLUMAZENIL [J].
BISHOP, KI ;
CURRAN, HV .
PSYCHOPHARMACOLOGY, 1995, 121 (02) :267-278
[4]  
Bishop KI, 1996, EXP CLIN PSYCHOPHARM, V4, P292
[5]   INVESTIGATING DISSOCIATIONS AMONG MEMORY MEASURES - SUPPORT FOR A TRANSFER-APPROPRIATE PROCESSING FRAMEWORK [J].
BLAXTON, TA .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-LEARNING MEMORY AND COGNITION, 1989, 15 (04) :657-668
[6]   IMPLICIT MEMORY AND TEST AWARENESS [J].
BOWERS, JS ;
SCHACTER, DL .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-LEARNING MEMORY AND COGNITION, 1990, 16 (03) :404-416
[7]   ABSENCE OF PRIMING COUPLED WITH SUBSTANTIALLY PRESERVED RECOGNITION IN LORAZEPAM-INDUCED AMNESIA [J].
BROWN, MW ;
BROWN, J ;
BOWES, JB .
QUARTERLY JOURNAL OF EXPERIMENTAL PSYCHOLOGY SECTION A-HUMAN EXPERIMENTAL PSYCHOLOGY, 1989, 41 (03) :599-617
[8]   PERCEPTUAL AND CONCEPTUAL PRIMING IN AMNESIC AND ALCOHOLIC PATIENTS [J].
CARLESIMO, GA .
NEUROPSYCHOLOGIA, 1994, 32 (08) :903-921
[9]   DIFFERENTIAL AMNESIC PROPERTIES OF BENZODIAZEPINES - A DOSE-RESPONSE COMPARISON OF 2 DRUGS WITH SIMILAR ELIMINATION HALF-LIVES [J].
CURRAN, HV ;
SCHIWY, W ;
LADER, M .
PSYCHOPHARMACOLOGY, 1987, 92 (03) :358-364
[10]   MEMORY FUNCTIONS, ALPRAZOLAM AND EXPOSURE THERAPY - A CONTROLLED LONGITUDINAL-STUDY OF AGORAPHOBIA WITH PANIC DISORDER [J].
CURRAN, HV ;
BOND, A ;
OSULLIVAN, G ;
BRUCE, M ;
MARKS, I ;
LELLIOT, P ;
SHINE, P ;
LADER, M .
PSYCHOLOGICAL MEDICINE, 1994, 24 (04) :969-976